Objective: To characterize operating room practices among ophthalmologists in Connecticut pertaining to the use of the AAO surgical checklist and implant timeouts. Methods: Ophthalmologists in Connecticut were emailed an anonymous web-based 15-question survey to inquire about their practice settings, knowledge of the AAO checklist, surgical errors, use of surgical checklists and implant timeout...

1. Abraham N, Yoseff G, Michael B, Yoram E. Biocompatibility of the Ex-PRESS® miniature glaucoma drainage implant. J Glaucoma. 2003;12:275–80. 2. Gallego-Pinazo R, López-Sánchez E, Marín-Montiel J. Resultados postquirúrgicos en la cirugía combinada de glaucoma. Comparación del implante Ex-PRESS® con la trabeculectomía. Arch Soc Esp Oftalmol. 2009;84: 293–8. 3. Francis BA, Singh K, Lin SC, Hodap...

The American Academy of Ophthalmology recognizes that screening for diabetic retinopathy using validated digital imaging can be a sensitive and effective detection method. Such technology has not been demonstrated to be as effective, however, at detecting and quantifying the spectrum of other ophthalmic pathology that can accompany diabetic retinopathy, including cataract and glaucoma, which ar...

The American Academy of Ophthalmology recognizes that screening for diabetic retinopathy using appropriately validated digital image technology can be a sensitive and effective methodology. Such technology has not been demonstrated to be as effective, however, at detecting and quantifying the spectrum of other ophthalmic pathology that can accompany diabetic retinopathy, including cataract and ...

Intervention In the model, each patient was assessed for disease progression and mortality by age, disease duration, and disease severity. Screening for diabetic retinopathy was assumed to be done according to the guidelines of the American Academy of Ophthalmology, with assessments for proliferative retinopathy and macular edema that used published sensitivities for ophthalmic examination. Pat...

The American Academy of Ophthalmology recognizes that screening for diabetic retinopathy using appropriately validated digital image technology can be a sensitive and effective methodology. Such technology has not been demonstrated to be as effective, however, at detecting and quantifying the spectrum of other ophthalmic pathology that can accompany diabetic retinopathy, including cataract and ...